LRRK2 G2019S Transgenic Mice Display Increased Susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Mediated Neurotoxicity

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common causes of late onset autosomal dominant form of Parkinson disease (PD). Gain of kinase activity due to the substitution of Gly 2019 to Ser (G2019S) is the most common mutation in the kinase domain of LRRK2. Genetic predisposition...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Chem Neuroanat
Glavni autori: Karuppagounder, Senthilkumar S., Xiong, Yulan, Lee, Yunjong, Lawless, Maeve C., Kim, Donghyun, Nordquist, Emily, Martin, Ian, Ge, Preston, Brahmachari, Saurav, Jhaldiyal, Aanishaa, kumar, Manoj, Andrabi, Shaida A., Dawson, Ted M., Dawson, Valina L.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958044/
https://ncbi.nlm.nih.gov/pubmed/26808467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchemneu.2016.01.007
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items